Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
378.60    0.50 (0.13%)
Bid:
376.90
Ask:
377.10
Spread: 0.20 (0.053%)
Market Cap: £7.78b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Final Results

20 May 2026 07:00

RNS Number : 9971E
Marks and Spencer Group PLC
20 May 2026
 

MARKS AND SPENCER GROUP PLC

 

PRELIMINARY RESULTS FOR THE 52 WEEKS ENDED 28 MARCH 2026

 

Marks and Spencer Group plc (the "Company") announces its Preliminary Results for the 52 weeks ended 28 March 2026, which are available to view at: http://www.rns-pdf.londonstockexchange.com/rns/9971E_1-2026-5-19.pdf.

 

In compliance with UK Listing Rules 6.4.1(R) and 6.4.3(R), the Preliminary Results in unedited full text have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Preliminary Results are also available on the Company's corporate website at corporate.marksandspencer.com.

 

Dividend

The Board is proposing a final dividend of 3.0p per share, taking the full-year dividend to 4.2p per share, subject to shareholder approval at the forthcoming Annual General Meeting. If approved, the final dividend will be payable on 10 July 2026 to shareholders on the register of members as at close of business on 5 June 2026. The ordinary shares will be quoted ex dividend on 4 June 2026. For those shareholders electing to participate in the dividend reinvestment plan, the last date for receipt of a new election is 19 June 2026.

 

For further information, please contact:

 

Investor Relations

Fraser Ramzan: +44 (0) 7554 227 758

Helen Lee: +44 (0) 7880 294 990

 

Media Enquiries:

Corporate Press Office: +44 (0) 20 8718 1919

 

Investor & Analyst presentation and Q&A: 

A pre-recorded investor and analyst presentation will be available on the Marks and Spencer Group plc website here from 7:30am on 20 May 2026.

 

Stuart Machin and Alison Dolan will host a Q&A session at 9:30am on 20 May 2026.

 

For the quickest joining experience, please register prior to attending the call here. After registering, you will be given unique dial in details to join the call.

 

Alternatively, you can use the below details to join the call but please join 5-10 minutes before the start time in order to register your details with the operator.

 

Dial in:  +44 (0) 33 0551 0200

Passcode: Quote M&S FY Analyst when prompted by the operator.

Replay: A recording will be available after the call here.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR SFMEEUEMSELI
Date   Source Headline
12th Oct 202212:00 pmRNSMarks and Spencer Group Investor Presentation
3rd Oct 20229:00 amRNSTotal Voting Rights
30th Sep 202211:55 amRNSMarks & Spencer completes acquisition of Gist
28th Sep 202212:28 pmRNSDirector/PDMR Shareholding
27th Sep 20224:31 pmRNSHolding(s) in Company
13th Sep 20227:17 amRNSTrading update for Ocado Retail Limited
12th Sep 20222:25 pmRNSHolding(s) in Company
1st Sep 20229:00 amRNSTotal Voting Rights
1st Sep 20229:00 amRNSBlock listing Interim Review
31st Aug 20224:06 pmRNSDirector/PDMR Shareholding
1st Aug 20229:00 amRNSTotal Voting Rights
29th Jul 20224:11 pmRNSHolding(s) in Company
28th Jul 20224:30 pmRNSHolding(s) in Company
28th Jul 20224:08 pmRNSDirector/PDMR Shareholding
21st Jul 20229:00 amRNSM&S to acquire Gist Limited
21st Jul 20227:00 amRNSDirectorate Change
7th Jul 202212:31 pmRNSDirector/PDMR Shareholding
5th Jul 20223:08 pmRNSResult of AGM
1st Jul 20229:00 amRNSTotal Voting Rights
28th Jun 20221:31 pmRNSDirector/PDMR Shareholding
24th Jun 20223:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20229:30 amRNSDirector/PDMR Shareholding
20th Jun 20229:21 amRNSNew Managing Director of M&S Food
16th Jun 20229:00 amRNSDirectorate Change
7th Jun 202210:05 amRNSDirectorate Change
7th Jun 202210:00 amRNSAnnual Financial Report
1st Jun 20229:00 amRNSTotal Voting Rights
30th May 20221:46 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSFinal Results
3rd May 20229:00 amRNSTotal Voting Rights
28th Apr 20222:12 pmRNSDirector/PDMR Shareholding
20th Apr 20223:34 pmRNSHolding(s) in Company
1st Apr 20229:00 amRNSTotal Voting Rights
29th Mar 20221:20 pmRNSDirector/PDMR Shareholding
11th Mar 20224:19 pmRNSHolding(s) in Company
10th Mar 20222:07 pmRNSM&S Appoints Strong New Leadership Team
10th Mar 20222:03 pmRNSSteve Rowe to Step Down as CEO of M&S
1st Mar 202212:11 pmRNSDirector/PDMR Shareholding
1st Mar 20229:00 amRNSTotal Voting Rights
18th Feb 20222:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:11 amRNSDirector/PDMR Shareholding
1st Feb 20229:00 amRNSTotal Voting Rights
28th Jan 202211:36 amRNSDirector/PDMR Shareholding
13th Jan 20227:00 amRNSChristmas 2021/2022 Trading Statement
4th Jan 20229:00 amRNSTotal Voting Rights
4th Jan 20229:00 amRNSBlock listing Interim Review
30th Dec 202111:00 amRNSDirector/PDMR Shareholding
21st Dec 20219:00 amRNS2021 PSP Award Targets
15th Dec 20219:30 amRNSM&S Signs New RCF Linked to Net Zero Targets
13th Dec 202111:00 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.